Skip to main content
. 2011 Jul 29;69(2):415–424. doi: 10.1007/s00280-011-1704-y

Fig. 2.

Fig. 2

Kaplan–Meier estimates of patients treated with GTX as first-line therapy with a locally advanced and b metastatic pancreatic cancer